<DOC>
	<DOC>NCT01089309</DOC>
	<brief_summary>The present study investigated the long-term (12 months) effect of spironolactone treatment on glucose homeostasis, metabolic parameters and vascular properties.</brief_summary>
	<brief_title>Effect of Aldosterone Blockade on Arterial Compliance</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>1. patients with type 2 diabetes mellitus 1. history of unstable angina, myocardial infarction (MI), cerebrovascular accident (CVA) 2. major surgery within the six months preceding entrance to the study 3. unbalanced endocrine disease 4. any disease that might affect absorption of medications 5. plasma creatinine &gt;2.5 mg/dl 6. elevation of liver enzymes to more that twice the upper normal limit 7. plasma potassium levels &gt;5.5 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Aldosterone Blockade</keyword>
	<keyword>Arterial elasticity</keyword>
	<keyword>Glycemic control</keyword>
</DOC>